Cabotegravir approval welcomed: now it must be made available as soon as possible
Last Updated:A simple injection six times a year can take us to the next stage in the fight against the HIV epidemic.
Latest news
Read the latest news from National AIDS Trust.
Our response to the UKHSA’s latest HIV data
Last Updated:We comment on the UKHSA's latest HIV data.
The 10 Year Health Plan must deliver to stop new HIV cases
Last Updated:To make the vision of the Plan a reality, we must see sustained investment in the NHS, stronger NHS partnerships with community organisations, and a continued focus on tackling inequalities.
Position of HIV organisations on trans rights and the Equality and Human Rights Commission’s draft Code of Practice
Last Updated:HIV organisations have come together to call for the EHRC draft guidelines to be withdrawn
Inequalities remain in new STI data
Last Updated:Rollout of opt-out HIV testing in hospital emergency departments, and year-round postal testing are vital to end new cases 2030.
Cuts to the global HIV response to have devastating impact
Last Updated:We call on the UK and all other donor countries to change course.
Prime Minister takes HIV test to mark National HIV Testing Week
Last Updated:Prime Minister Keir Starmer has become the first serving G7 leader to take a public HIV test.
National AIDS Trust welcomes Scotland’s decision on long-acting injectable PrEP
Last Updated:Cabotegravir (CAB-LA) will help close the prevention gap for people who face barriers to adhering to oral PrEP.
Statement on the impact of PEPFAR funding cuts
Last Updated:A statement from National AIDS Trust following reports of potential cuts to PEPFAR funding, which provides treatment and services to millions of people overseas.